BioAegis Therapeutics, Inc. — Form D/A

BioAegis Therapeutics, Inc. of Morristown, NJ, a company, filed a Form D amendment with the SEC on 2015-04-17. $8.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Steve CordovanoExecutive OfficerMorristown, NJ
Valerie CevaDirectorMorristown, NJ
Valerie CevaExecutive OfficerMorristown, NJ
Mark DiNubileDirectorMorristown, NJ
Mark DiNubileExecutive OfficerMorristown, NJ
Susan LevinsonDirectorMorristown, NJ
Susan LevinsonExecutive OfficerMorristown, NJ
John StosselDirectorMorristown, NJ
Thomas StosselDirectorNorth Brunswick, NJ
Thomas StosselExecutive OfficerNorth Brunswick, NJ
Steven CordovanoExecutive OfficerNorth Brunswick, NJ
Susan L LevinsonDirectorMorristown, NJ
Susan L LevinsonExecutive OfficerMorristown, NJ
Valerie L CevaDirectorNew York, NY
Valerie L CevaExecutive OfficerNew York, NY
Thomas L StosselDirectorBelmont, MA
Steven L CordovanoExecutive OfficerRowayton, CT

Other filings by this issuer (8)

FiledFormOfferingSold
2022-05-11D$21.8M$21.8M
2020-10-07D/A$7.0M$7.0M
2020-06-17D$5.0M$5.0M
2018-09-26D$7.0M$4.1M
2016-03-14D$5.0M$1.5M
2014-02-07D/A$6.0M$3.7M
2013-02-08D/A$6.0M$3.1M
2012-04-11D$6.0M$497K

More